#JITC Research: Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer https://t.co/w2I5SEJawu https://t.co/LzX5yMougt
RT @TIL_Radboudumc: Harm Westdorp and Jeroen Creemers (group of Jolanda de Vries) reported that vaccination with blood-derived myeloid dend…
RT @TIL_Radboudumc: Harm Westdorp and Jeroen Creemers (group of Jolanda de Vries) reported that vaccination with blood-derived myeloid dend…
RT @TIL_Radboudumc: Harm Westdorp and Jeroen Creemers (group of Jolanda de Vries) reported that vaccination with blood-derived myeloid dend…
Harm Westdorp and Jeroen Creemers (group of Jolanda de Vries) reported that vaccination with blood-derived myeloid dendritic cells (cDC2) and/or plasmacytoid dendritic cells (pDC) induced tumor antigen-specific immune responses in patients @jitcancer http
New #JITC Research: Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer https://t.co/w2I5SEJawu https://t.co/UsCNJfLmeR
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer. https://t.co/yTOrs201mc
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer | Journal for ImmunoTherapy ... https://t.co/5vAj3Q6YuW https://t.co/CKEcdI2qhw